The way NICE reviews new medicines is about to go through its biggest change in years – but what do the proposals mean for the future of drug development in the UK?
The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as 'comprehensive', the 'biggest yet'. But a closer inspection of the EU-UK Trade and
If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufa
